Transcranial Magnetic Stimulation (TMS) for CRPS

Complex Regional Pain Syndrome (CRPS) Clinical Trial

Official title:

Transcranial Magnetic Stimulation for CRPS

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02067273
• Other study ID #: 25894-2
• Status: Completed
• Phase: N/A
• First received: February 13, 2014
• Last updated: May 11, 2017
• Start date: February 2014
• Est. completion date: March 2015

Study information

• Verified date: May 2017
• Source: Stanford University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this pilot study is to test the durability of response to Transcranial Magnetic Stimulation (TMS) for the symptoms of Complex Regional Pain Syndrome (CRPS). The investigators will test various methods of TMS for varying lengths of time in a pilot study to investigate what the clinical impact.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: March 2015
• Est. primary completion date: February 2015
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age 18 or older

• Diagnosis of CRPS (complex regional pain syndrome)

• Average pain level reported on Numerical Rating Scale meets entry criteria

• Ability to perform the experimental task and procedures.

Exclusion Criteria:

• MRI contraindication (metal implants or devices, claustrophobia)

• TMS Contraindication (eg metal implant or devices near the site of stimulation)

• History of epilepsy

• History of a psychological or psychiatric disorder that would interfere with study procedures, at the discretion of the researcher.

• Neurologic illness that would interfere with brain integrity

• Current medical condition or medication use that would interfere with study procedures or data integrity, at the discretion of the researcher.

• Currently pregnant or planning to become pregnant.

• On going legal action or disability claim.

Related Conditions & MeSH terms

• Complex Regional Pain Syndrome (CRPS)
• Complex Regional Pain Syndromes
• Reflex Sympathetic Dystrophy

Intervention

Device:
• Transcranial Magnetic Stimulation (TMS)

Locations

Country	Name	City	State
United States	Stanford University School of Medicine	Palo Alto	California

Sponsors (1)

Lead Sponsor	Collaborator
Stanford University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Present Pain Intensity	Present pain intensity was reported by participants using a visual analog scale (VAS) from scores ranging from 1-10; lower scores represent less pain, higher scores represent more severe pain.	Baseline, post-treatment, one week follow-up

External Links

•   Link